Thematics Asset Management Has $15.44 Million Stake in Danaher Corporation $DHR

Thematics Asset Management raised its position in shares of Danaher Corporation (NYSE:DHR) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 75,301 shares of the conglomerate’s stock after purchasing an additional 1,805 shares during the quarter. Thematics Asset Management’s holdings in Danaher were worth $15,437,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the business. ICONIQ Capital LLC raised its position in Danaher by 86.1% during the first quarter. ICONIQ Capital LLC now owns 2,134 shares of the conglomerate’s stock valued at $437,000 after buying an additional 987 shares during the period. Quantitative Investment Management LLC grew its stake in Danaher by 58.0% during the 1st quarter. Quantitative Investment Management LLC now owns 52,711 shares of the conglomerate’s stock valued at $10,805,000 after acquiring an additional 19,359 shares in the last quarter. Jump Financial LLC increased its holdings in shares of Danaher by 107.4% in the 1st quarter. Jump Financial LLC now owns 120,176 shares of the conglomerate’s stock valued at $24,636,000 after purchasing an additional 62,235 shares during the period. Cadence Bank lifted its position in shares of Danaher by 3.1% in the first quarter. Cadence Bank now owns 11,726 shares of the conglomerate’s stock worth $2,404,000 after purchasing an additional 355 shares in the last quarter. Finally, APG Asset Management N.V. boosted its holdings in shares of Danaher by 4.3% during the first quarter. APG Asset Management N.V. now owns 704,616 shares of the conglomerate’s stock worth $133,722,000 after purchasing an additional 28,808 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several research reports. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. UBS Group dropped their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Barclays reissued an “overweight” rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Deutsche Bank Aktiengesellschaft cut their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $247.61.

Danaher Stock Up 3.8%

Shares of DHR stock opened at $211.7060 on Friday. The stock’s 50 day simple moving average is $200.67 and its 200 day simple moving average is $199.44. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market capitalization of $151.59 billion, a price-to-earnings ratio of 45.04, a PEG ratio of 2.96 and a beta of 0.73.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the company posted $1.72 earnings per share. The company’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.